<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The case histories of 72 subsequently treated patients - 44 with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, 10 with <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo>, 16 with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and 2 with <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> - were analyzed after bone marrow transplantation (BMT) with respect to <z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">pulmonary diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Thirty-eight patients suffered from a total of 51 pulmonary complications, which led to <z:hpo ids='HP_0011420'>death</z:hpo> in 20 </plain></SENT>
<SENT sid="2" pm="."><plain>Of 13 patients, 3 died of <z:mp ids='MP_0001794'>bacterial</z:mp> <z:hpo ids='HP_0002090'>pneumonia</z:hpo>, <z:hpo ids='HP_0000001'>all</z:hpo> of them during <z:hpo ids='HP_0001913'>granulocytopenia</z:hpo>; 2 of 6 patients died of fungal <z:hpo ids='HP_0002090'>pneumonia</z:hpo> and 2 out of 3 of a mixed <z:mp ids='MP_0001794'>bacterial</z:mp>-mycotic <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Adult <z:hpo ids='HP_0002098'>respiratory distress</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ARDS</z:e>) led to <z:hpo ids='HP_0011420'>death</z:hpo> in 2 patients </plain></SENT>
<SENT sid="4" pm="."><plain>A granulocyte count under 500/microliter correlated significantly (P less than 0.002) with the fatal outcome of <z:mp ids='MP_0001794'>bacterial</z:mp>, fungal and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ARDS</z:e> <z:hpo ids='HP_0002090'>pneumonia</z:hpo> as well as with <z:e sem="disease" ids="C0006277" disease_type="Disease or Syndrome" abbrv="">bronchitis</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0001799'>Viral</z:mp> <z:hpo ids='HP_0002090'>pneumonia</z:hpo> led to <z:hpo ids='HP_0011420'>death</z:hpo> in 8 of 9 patients; in each there was a significant correlation (P less than 0.05) with <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (GvHD) </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with repeated episodes of pulmonary illness had significantly more <z:hpo ids='HP_0011010'>chronic</z:hpo> GvHD (P less than 0.05); several of these patients displayed a reduction in helper T cells and an increase in suppressor T cells in the peripheral blood </plain></SENT>
<SENT sid="7" pm="."><plain>The natural killer (NK) cells were reduced and the percentage of activated NK cell level lay between 6% and 69% </plain></SENT>
<SENT sid="8" pm="."><plain>B-cells were absent or deficient </plain></SENT>
<SENT sid="9" pm="."><plain>These findings explain in part the absence of specific antibody reactivity </plain></SENT>
<SENT sid="10" pm="."><plain>Five of these patients also contracted GvHD-associated obstructive <z:hpo ids='HP_0011950'>bronchiolitis</z:hpo>, which did not respond to therapy </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0002113'>Pulmonary infiltrates</z:hpo> of unknown origin (including idiopathic interstitial <z:hpo ids='HP_0002090'>pneumonia</z:hpo>) occurred in 8 of the patients (11.1%), with a fatal outcome in 3 patients </plain></SENT>
<SENT sid="12" pm="."><plain>Significant changes (P less than 0.05) in lung function after BMT appeared in the form of <z:hpo ids='HP_0002792'>reduced vital capacity</z:hpo> (VC) increased residual volume (RV) and an increase in RV expressed as the percentage of total lung capacity </plain></SENT>
<SENT sid="13" pm="."><plain><z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">Pulmonary diseases</z:e> were the most common complication and cause of <z:hpo ids='HP_0011420'>death</z:hpo> in our patients after BMT </plain></SENT>
</text></document>